Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|
Free Cash Flow | $2,734.0K | ($46.6M) | ($85.1M) | ($26.5M) | ($57.4M) |
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
As of today, LifeStance Health Group, Inc.'s last 12-month Free Cash Flow is $35.1M, based on the financial report for Sep 30, 2024 (Q3 2024).
Over the last year, LifeStance Health Group, Inc.'s Free Cash Flow growth was N/A. The average annual Free Cash Flow growth rates for LifeStance Health Group, Inc. have been N/A over the past three years, N/A over the past five years.